In his new book, Prof. Weitz emphasizes how COVID-19 is evolving away from the heights of the pandemic and toward a seasonal endemic disease, characterized by silent asymptomatic spread, which complicates containment.
ASSURE In the News
In his new book, Prof. Weitz emphasizes how COVID-19 is evolving away from the heights of the pandemic and toward a seasonal endemic disease, characterized by silent asymptomatic spread, which complicates containment.
On December 22, 2022, Oceanit’s ASSURE-100 received FDA Over-The-Counter authorization. The ASSURE-100 Rapid COVID-19 Home Test authorization, an over-the-counter home test, comes ten months after initial point-of-care EUA was granted on February 28, 2022.
Oceanit receives U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the ASSURE-100 rapid antigen test for detection of COVID-19.
Oceanit’s ASSURE-19 Covid-19 test was selected as a semifinalist from a pool of nearly 700 teams from around the world competing for the XPRIZE for Rapid Covid Testing. We will now perform blind proficiency testing on inactive virus samples sent to us by the XPRIZE Foundation as the next step towards becoming a finalist for the award.